688658 悦康药业
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额168,334438,241785,492(121,169)515,239
投资活动产生之现金流量净额(401,588)(545,759)(502,047)(556,545)(200,836)
筹资活动产生之现金流量净额(23,316)(28,460)(432,192)(101,604)(408,276)
汇率变动对现金及现金等价物的影响1702643,9366,203(913)
现金及现金等价物净增加/(减少)(256,400)(135,714)(144,812)(773,115)(94,786)
期初现金及现金等价物余额1,237,8191,373,5331,518,3452,291,4602,386,246
期末现金及现金等价物余额981,4191,237,8191,373,5331,518,3452,291,460